AI assistant
REACH RESOURCES LIMITED — Capital/Financing Update 2021
Jan 17, 2021
65731_rns_2021-01-17_e684b961-2be9-4f99-a1d6-8b6441fec2aa.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer

Announcement Summary
Entity name CERVANTES CORPORATION LIMITED
Announcement Type
New announcement
Date of this announcement
Friday January 15, 2021
The Proposed issue is:
A non pro rata offer of securities under a disclosure document or product disclosure statement (PDS)
Total number of +securities proposed to be issued for a non pro rata offer of securities under a disclosure document or product disclosure statement (PDS)
| ASX +security code | +Security description | Maximum Number of+securities to be issued |
|---|---|---|
| CVS | ORDINARY FULLY PAID | 1,000 |
Closing date for receipt of acceptances Monday April 12, 2021
Proposed +issue date
Tuesday April 13, 2021
Refer to next page for full details of the announcement

Part 1 - Entity and announcement details
1.1 Name of +Entity
CERVANTES CORPORATION LIMITED
We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.
1.2 Registered Number Type
ABN
Registration Number
79097982235
1.3 ASX issuer code
CVS
1.4 The announcement is
New announcement
1.5 Date of this announcement
Friday January 15, 2021
1.6 The Proposed issue is:
A non-+pro rata offer of +securities under a +disclosure document or +PDS

Part 5 - Details of proposed non-pro rata offer under a disclosure document or PDS
Part 5A - Conditions
5A.1 - Are any of the following approvals required for the non-+pro rata offer of +securities under a +disclosure document or +PDS?
- +Security holder approval
- Court approval
- Lodgement of court order with +ASIC
- ACCC approval
- FIRB approval
- Another approval/condition external to the entity
No
Part 5B - Offer details
Is the proposed security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional securities in a class that is already quoted or recorded by ASX)? Existing class
Will the proposed issue of this +security include an offer of attaching +securities? No
Details of +securities proposed to be issued
ASX +security code and description
CVS : ORDINARY FULLY PAID
The number of +securities to be offered under the +disclosure document or +PDS
1,000
Will the offer be conditional on applications for a minimum number of +securities being received or a minimum amount being raised (i.e. a minimum subscription condition)? No
Will individual security holders be required to accept the offer for a minimum number or value of +securities (i.e. a minimum acceptance condition)? No

Will individual security holders be limited to accepting the offer for a maximum number or value of +securities (i.e. a maximum acceptance condition)? No
Offer price details
Has the offer price been determined? Yes
In what currency will the offer be made? What is the offer price per +security? AUD 0.00800
AUD - Australian Dollar
Oversubscription & Scale back details
Will the entity be entitled to accept over-subscriptions? No
Will a scale back be applied if the offer is over-subscribed? No
Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class? Yes
Part 5C - Timetable
5C.1 Lodgement date of +disclosure document or +PDS with ASIC
Friday January 15, 2021
5C.2 Date when +disclosure document or +PDS and acceptance forms will be made available to investors
Monday January 18, 2021
5C.3 Offer open date
Friday March 12, 2021
5C.4 Closing date for receipt of acceptances
Monday April 12, 2021
5C.6 Proposed +issue date
Tuesday April 13, 2021

Part 5D - Listing Rule requirements
5D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1? No
5D.1b Are any of the +securities proposed to be issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? No
5D.1c Are any of the +securities proposed to be issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)? No
5D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue? No
Part 5E - Fees and expenses
5E.1 Will there be a lead manager or broker to the proposed offer? No
5E.2 Is the proposed offer to be underwritten? No
5E.3 Will brokers who lodge acceptances or renunciations on behalf of eligible +security holders be paid a handling fee or commission? No
5E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed offer
Part 5F - Further Information
5F.01 The purpose(s) for which the entity intends to use the cash raised by the proposed issue
The Company is seeking to raise only a nominal amount of $8 under the Cleansing Offer as the purpose of the Cleansing Offer is not to raise capital
5F.1 Will the entity be changing its dividend/distribution policy if the proposed offer is successful? No

5F.2 Please explain the entity's allocation policy for the offer, including whether or not acceptances from existing +security holders will be given priority
The Cleansing Offer will only be extended to specific parties on invitation from the Directors. Applications for Shares under the Cleansing Offer should only be made if you are instructed to do so by the Company.
5F.3 URL on the entity's website where investors can download the +disclosure document or +PDS
5F.4 Any other information the entity wishes to provide about the proposed offer
The primary purpose of the Cleansing Offer is to remove any trading restrictions that would otherwise attach to Shares that may be issued by the Company without disclosure under Chapter 6D of the Corporations Act prior to the closing date of the Cleansing Offer.